INHIBITORY EFFECT OF MAGNESIUM L-ASCORBYL-2-PHOSPHATE (VC-PMG) ON MELANOGENESIS IN-VITRO AND IN-VIVO

Citation
K. Kameyama et al., INHIBITORY EFFECT OF MAGNESIUM L-ASCORBYL-2-PHOSPHATE (VC-PMG) ON MELANOGENESIS IN-VITRO AND IN-VIVO, Journal of the American Academy of Dermatology, 34(1), 1996, pp. 29-33
Citations number
33
Categorie Soggetti
Dermatology & Venereal Diseases
ISSN journal
01909622
Volume
34
Issue
1
Year of publication
1996
Pages
29 - 33
Database
ISI
SICI code
0190-9622(1996)34:1<29:IEOML(>2.0.ZU;2-D
Abstract
Background: An inhibitory effect of ascorbic acid (AsA) on melanogenes is has been described. However, AsA is quickly oxidized and decomposed in aqueous solution and thus is not generally useful as a depigmentin g agent. Objective: Our purpose was to examine the effect on pigmentat ion of magnesium-L-ascorbyl-2-phosphate (VC-PMG), a stable derivative of AsA. Methods: Percutaneous absorption of VC-PMG was examined in der matomed human skin, and its effect on melanin production by mammalian tyrosinase and human melanoma cells in culture was also measured. A 10 % VC-PMG cream was applied to the patients. Results: VC-PMG suppressed melanin formation by tyrosinase and melanoma cells. In situ experimen ts demonstrated that VC-PMG cream was absorbed into the epidermis and that 1.6% remained 48 hours after application. The lightening effect w as significant in 19 of 34 patients with chloasma or senile freckles a nd in 3 of 25 patients with normal skin. Conclusion: VC-PMG is effecti ve in reducing skin hyperpigmentation in some patients.